Literature DB >> 20926766

Tetrahydrobiopterin does not affect end-organ responsiveness to norepinephrine-mediated vasoconstriction in aged skin.

James A Lang1, Lacy A Holowatz, W Larry Kenney.   

Abstract

We have recently demonstrated that tetrahydrobiopterin (BH(4)) augments reflex vasoconstriction (VC) in aged skin. Although this appears to occur through its role in norepinephrine (NE) biosynthesis, the extent with which vascular mechanisms are affected are unknown. We hypothesized that localized BH(4) supplementation would not affect the VC response to exogenous NE when sympathetic nerves were blocked. Two microdialysis fibers were placed in bretylium tosylate pretreated (presynaptically blocks neurotransmitter release from sympathetic adrenergic nerve terminals; iontophoresis, 200 μA for 20 min) 3-cm(2) forearm skin of 10 young (Y) and 10 older (O) subjects for perfusion of 1) Ringer (control) and 2) 5 mM BH(4). While local skin temperature was clamped at 34°C, six concentrations of NE (10(-12), 10(-10), 10(-8), 10(-6), 10(-4), 10(-2) M) were infused at each drug-treated site. Cutaneous vascular conductance (CVC) was calculated (CVC = laser Doppler flux/mean arterial pressure) and normalized to baseline (%ΔCVC(base)). Despite prejunctional adrenergic blockade, NE-mediated VC was blunted in aged skin at each NE dose (10(-12): -12 ± 2 vs. -21 ± 2; 10(-10): -15 ± 2 vs. -27 ± 1; 10(-8): -22 ± 2 vs. -32 ± 2; 10(-6): -27 ± 2 vs. -38 ± 1; 10(-4): -52 ± 3 vs. -66 ± 5; 10(-2): -62 ± 3 vs. -75 ± 4%ΔCVC(base); P < 0.01), and this response was not affected by pretreatment with BH(4) (P > 0.05). Localized BH(4) did not affect end-organ responsiveness to exogenous NE, suggesting that the effects of BH(4) on cutaneous VC are primarily isolated to the NE biosynthetic pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926766      PMCID: PMC3007192          DOI: 10.1152/ajpregu.00138.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  40 in total

1.  Effect of age on cutaneous vasoconstrictor responses to norepinephrine in humans.

Authors:  Thad E Wilson; Kevin D Monahan; Daniel S Short; Chester A Ray
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-11       Impact factor: 3.619

Review 2.  Intricate regulation of tyrosine hydroxylase activity and gene expression.

Authors:  S C Kumer; K E Vrana
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

3.  Cutaneous vasoconstrictor responses to norepinephrine are attenuated in older humans.

Authors:  Caitlin S Thompson; Lacy A Holowatz; W Larry Kenney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-01-20       Impact factor: 3.619

Review 4.  Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.

Authors:  An L Moens; David A Kass
Journal:  J Cardiovasc Pharmacol       Date:  2007-09       Impact factor: 3.105

5.  Aging and forearm postjunctional alpha-adrenergic vasoconstriction in healthy men.

Authors:  Frank A Dinenno; Niki M Dietz; Michael J Joyner
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

Review 6.  Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects.

Authors:  Zvonimir S Katusic; Livius V d'Uscio; Karl A Nath
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

7.  Reflex vasoconstriction in aged human skin increasingly relies on Rho kinase-dependent mechanisms during whole body cooling.

Authors:  James A Lang; John D Jennings; Lacy A Holowatz; W Larry Kenney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

8.  Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia.

Authors:  F Cosentino; D Hürlimann; C Delli Gatti; R Chenevard; N Blau; N J Alp; K M Channon; M Eto; P Lerch; F Enseleit; F Ruschitzka; M Volpe; T F Lüscher; G Noll
Journal:  Heart       Date:  2007-10-04       Impact factor: 5.994

9.  Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias.

Authors:  H J Duff; D M Roden; A Yacobi; D Robertson; T Wang; R J Maffucci; J A Oates; R L Woosley
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778

10.  Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin.

Authors:  Jan Bert Gramsbergen; Mats Sandberg; Annette Møller Dall; Brian Kornblit; Jens Zimmer
Journal:  Brain Res       Date:  2002-05-10       Impact factor: 3.252

View more
  5 in total

1.  Age- and limb-related differences in the vasoconstrictor response to limb dependency are not mediated by a sympathetic mechanism in humans.

Authors:  K A M Snyder; S Shamimi-Noori; T E Wilson; K D Monahan
Journal:  Acta Physiol (Oxf)       Date:  2012-02-18       Impact factor: 6.311

2.  Oral clopidogrel improves cutaneous microvascular function through EDHF-dependent mechanisms in middle-aged humans.

Authors:  Jessica D Dahmus; Rebecca S Bruning; W Larry Kenney; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-26       Impact factor: 3.619

3.  Endothelial function is impaired in the cutaneous microcirculation of adults with psoriasis through reductions in nitric oxide-dependent vasodilation.

Authors:  Billie K Alba; Jody L Greaney; Sara B Ferguson; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-20       Impact factor: 4.733

4.  Acute tetrahydrobiopterin supplementation attenuates sympathetic vasoconstrictor responsiveness in resting and contracting skeletal muscle of healthy rats.

Authors:  Nicholas G Jendzjowsky; Timothy P Just; Kelvin E Jones; Darren S DeLorey
Journal:  Physiol Rep       Date:  2014-10-15

5.  Oral sapropterin augments reflex vasoconstriction in aged human skin through noradrenergic mechanisms.

Authors:  Anna E Stanhewicz; Lacy M Alexander; W Larry Kenney
Journal:  J Appl Physiol (1985)       Date:  2013-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.